Company: ZVRA
Filing Date: 2025-04-21
Form Type: DEFC14A
Source: 0001193125-25-086293
Chunk: 56

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-04-21
Form: DEFC14A
Chunk 56
---
 elements of our compensation program. |

Base Salary The base salaries of our NEOs are an important part of their total compensation package, intended to reflect their respective positions, duties and responsibilities. Our NEOs receive base salary to compensate them for satisfactory performance of their duties to our Company. The base salary payable to each NEO is intended to provide a visible and stable fixed component of compensation, reflecting the executive’s skill set, experience, role and responsibilities. Base salaries provide our NEOs with a reasonable degree of financial certainty and stability. Our Compensation Committee periodically reviews NEO base salaries in consultation with management and the committee’s compensation consultant to determine whether any adjustments are necessary or appropriate. The following table shows the annual base salaries of our NEOs for 2023, 2024 and 2025. All annual base salary increases were effective March 1 of the given year.

| Name                         |     | 2023 AnnualBase Salary ($) |     | 2024 AnnualBase Salary ($) |     | 2025 AnnualBase Salary ($) |
| Neil F. McFarlane            |     |                   $700,000 |     |                   $700,000 |     |                   $735,000 |
| Adrian Quartel, M.D., FFPM   |     |                        N/A |     |                   $485,000 |     |                   $500,000 |
| R. LaDuane Clifton, MBA, CPA |     |                   $446,000 |     |                   $463,800 |     |                   $480,000 |

Cash-BasedIncentive Compensation Our NEOs generally have the opportunity to earn annual performance bonuses based on the achievement of short-term performance goals. The NEOs’ 2024 target annual cash bonuses, expressed as a percentage of base salary, were: 60% for Mr. McFarlane and 40% for the other two NEOs. Our Compensation Committee generally determines annual bonuses for our NEOs by multiplying (a) base salary, by (b) target cash bonus percentage, by (c) the level of achievement of corporate and/or individual performance objectives (if applicable). Up to an additional 40% of each individual’s target bonus may be earned for outperformance based on certain bonus enhancements, as described below. In addition, the Compensation Committee retains discretion to adjust annual bonuses as it determines appropriate to reflect Company performance, individual performance or other factors that the Compensation Committee believes to be appropriate. The annual performance bonuses for 2024 were weighted 100% on corporate objectives. Corporate goals were